|
|
||||||||
R-mediated phagocytosis by human macrophages involves Hck, Syk, and Pyk2 and is augmented by GM-CSF



* AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical Research, and National Centre for HIV Virology Research, Fairfield;
Department of Medicine, Monash University, Prahran; and
Department of Medical Laboratory Science, Royal Melbourne Institute of Technology, Bundoora, Australia
Correspondence: Suzanne Crowe, AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical Research, Yarra Bend Rd., Fairfield, 3078 Melbourne, Australia. E-mail: crowe{at}burnet.edu.au
| ABSTRACT |
|---|
|
|
|---|
R) are
widely expressed on cells of hemopoietic lineage and plays an important
role in host defense. We investigated the signaling pathways during
Fc
R-mediated phagocytosis in human monocyte-derived macrophages
(MDMs) and examined the effect of granulocyte-macrophage
colony-stimulating factor (GM-CSF) on these events. Fc
R-mediated
phagocytosis resulted in enhanced tyrosine phosphorylation of a wide
range of cellular proteins and activation of tyrosine kinases Hck, Syk,
and Pyk2, as well as the multidomain adapter protein paxillin.
Stimulation of MDMs with GM-CSF augmented Fc
R-mediated phagocytosis
and increased the levels of tyrosine phosphorylation in phagocytosing
MDM cultures, indicating tyrosine kinase-mediated activation. GM-CSF
treatment of MDMs without a phagocytic stimulus did not activate Syk,
suggesting that GM-CSF may act either distally to Syk in the
Fc
R-mediated signaling cascade or on a parallel pathway activated by
the Fc
R. This study shows that early signaling events during
Fc
R-mediated phagocytosis in human MDMs involve activation of Syk,
Hck, and paxillin. It also provides the first evidence for Pyk2
activation during phagocytosis and a baseline for further studies on
the effect of GM-CSF on Fc
R-mediated phagocytosis.
Key Words: paxillin monocyte-derived macrophage tyrosine kinase signaling
| INTRODUCTION |
|---|
|
|
|---|
RI, Fc
RII, and Fc
RIIIA) are the major means by which cells
of the monocyte/macrophage lineage recognize IgG-opsonized particles
and promote host defenses, including phagocytosis, antibody-dependent
cellular cytotoxicity, and cytokine and chemokine secretion. The major
Fc
receptors expressed on monocytes are the high-affinity Fc
RI
(CD64) and a low-affinity Fc
RII (CD32), whereas macrophages also
express Fc
RIIIA (CD16) [reviewed in reference 1]. Most studies
delineating the specific signaling events during Fc
R-mediated
phagocytosis have been performed using murine macrophages
[2
3
4
5
6
7
] or cell lines transfected with Fc
R
[8
9
10
], with only two studies done in human macrophages
[11
] or monocytes [12
]. Several signal
transduction pathways utilized by macrophages activated during
Fc
R-mediated phagocytosis have been described [reviewed in 13],
including requirements for isoforms of protein kinase C
[12
], phosphatidylinositol 3-kinase [14
,
15
], and the Rho family of GTPases [16
,
17
]. These signaling events are initiated after
clustering of Fc
R via activation of tyrosine kinases of the Src
family [18
, 19
]. Src kinase activation
results in the rapid and transient phosphorylation of immunoreceptor
tyrosine-based activation motifs (ITAMs) on either the ligand-binding
subunit in the cytoplasmic domain of Fc
RII or the associated
chain of Fc
RI and RIIIA [10
, 20
,
21
]. Phosphorylated ITAM motifs may represent docking
sites for Syk that allow its subsequent activation [22
,
23
]. A requirement for Syk in Fc
R-mediated
phagocytosis was firstly demonstrated in human monocytes by using
antisense oligodeoxynucleotides to eliminate Syk mRNA
[24
]. Gene knockout studies subsequently confirmed an
absolute and specific requirement for Syk in Fc
R-mediated
phagocytosis by murine macrophages [3
]. Macrophages
derived from the fetal livers of Syk-deficient mice had defective
Fc
R-mediated phagocytosis and actin assembly but unimpaired
phagocytosis of Escherichia coli, yeasts, or latex particles
[3
].
Activated Syk is thought to promote phosphorylation and localized
accumulation of a number of cytoskeletal substrates [reviewed in 25],
including the actin-binding proteins paxillin, vinculin, talin, and
-actinin [6
, 26
, 27
].
Paxillin, a multidomain adapter protein, is thought to interact with a
variety of proteins, such as focal adhesion kinase (FAK), Pyk2, and
Vav, and in this way it organizes focal adhesion complexes and
cytoskeletal rearrangement [reviewed in 28]. Human monocytes and
macrophages do not express FAK [29
], but they activate
and phosphorylate another member of the FAK family, Pyk2. This kinase
is 45% identical in amino acid sequence to FAK [30
] and
is shown to be involved in cytoskeletal engagement upon adherence and
subsequent calcium or PKC costimulatory activation in human monocytes
[29
]. A role for Pyk2 in phagocytosis has not yet been
reported.
Here we demonstrate that Fc
R-mediated internalization of
IgG-opsonized targets by human monocyte-derived macrophages (MDMs) was
dependent on protein tyrosine phosphorylation, with transient
activation of the protein tyrosine kinases Hck, Syk and Pyk2, and
redistribution of the multidomain adaptor protein paxillin between
Triton-soluble and Triton-insoluble cell fractions. In addition, acute
stimulation of MDMs with granulocyte-macrophage colony-stimulating
factor (GM-CSF) augmented phagocytosis of IgG-opsonized targets and
concomitantly tyrosine phosphorylation of cellular proteins in an
additive manner but did not activate Syk. These observations suggest
that GM-CSF might either stimulate phagocytic pathways activated by the
Fc
R downstream of Syk kinase or might do so independently of
Syk activation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Opsonization of target particles
Target particles were opsonized immediately prior to the
phagocytosis assay. Sheep red blood cells (E; ICN-Cappel, Aurora, OH)
were washed three times in phosphate-buffered saline (PBS; Trace
Biosciences, Castle Hill, Australia), and opsonized with a
subagglutinating titer (1:300) of rabbit anti-E antibody (ICN-Cappel,
Aurora, OH) for 30 min at room temperature. Cells were washed five
times in cold PBS and resuspended at a concentration of 1 x
108/mL in Iscoves medium. Latex beads (3 µm in
diameter; Sigma, St Louis, MO) were coated with bovine serum albumin
(BSA) by incubation in 1 mL of PBS containing 10 mg of BSA (Sigma)
overnight at 4°C, followed by five washes with cold PBS. Beads were
opsonized with 10% rabbit anti-BSA antiserum (ICN-Cappel, Aurora, OH)
for 30 min at room temperature, washed three times in PBS, and
resuspended in PBS at a concentration of 4 x 108
cells/mL.
Phagocytosis assay using IgG-opsonized E
On days 57 after isolation, MDMs were plated onto 96-well
plates (Costar, Cambridge, MA) at 5 x 104 cells per
well in 100 µL of supplemented Iscoves medium and allowed to adhere
for 2 h at 37°C in a 5% CO2 humidified incubator.
IgG-opsonized or unopsonized E was added to adhered MDMs at an E/MDM
ratio of 10:1. The plate was centrifuged at 100 g for 5 min
at 4°C and then placed at 37°C for phagocytosis to
proceed. Phagocytosis was terminated after 30 min by placing the plates
on ice and washing cells with ice-cold PBS. Phagocytosis of
erythrocytes was quantified by a colorimetric assay
[32
]. Briefly, after unbound E were removed by washing
with PBS, non-phagocytosed erythrocytes attached to MDMs were lysed
with 0.2% NaCl for 3 min, followed by three washes with warm Iscoves
medium. Phagocytosed erythrocytes were measured by reaction of
hemoglobin with 2,7-diaminoflurene (Sigma) after lysis of MDMs in
0.2 M Tris-HCl buffer containing 6 M urea. Absorbance was determined at
620 nm in a plate reader (Labsystems Multiskan, Helsinki, Finland) and
compared to a standard curve generated using known numbers of E
(ranging from 4x103 to 5x105). In selected
experiments MDMs were incubated with the protein tyrosine kinase
inhibitor Genistein (Calbiochem, Croydon, Australia) at concentrations
ranging from 0.1 to 30 µM at 37°C for 30 min prior to phagocytosis
assay.
Phagocytosis assays using IgG-opsonized beads
MDMs (2x106 cells) were dispensed into 4 mL
polypropylene tubes (Becton Dickinson, Paramus, NJ), washed twice in
calcium- and magnesium-free PBS (PBS-CMF; 500 g for 5 min),
and cooled on ice for 20 min in 100 µL of PBS-CMF. MDMs were
incubated with or without IgG-opsonized beads at 37°C in a
shaking-water bath with a target/MDM ratio of 10:1. At specified time
points, phagocytosis was arrested by plunging the tubes into ice and
washing the MDMs in ice-cold PBS-CMF, followed by centrifugation at
20,000 g for 30 s. For immunoblotting and
immunoprecipitation experiments, washed cells were lysed in 100 µL of
Triton lysis buffer containing 25 mM Tris-HCl (pH 7.5), 0.14 M NaCl, 1
mM EDTA, 1% Triton X-100, supplemented with phosphatase inhibitors
[50 mM NaF, 1 mM sodium orthovanadate (Sigma), 40 mM
ß-glycerophosphate (Sigma)], and the following protease inhibitors:
1 mM pefabloc, 1µM pepstatin, and 1 µM leupeptin
(Boehringer-Mannheim, Mannheim, Germany).
GM-CSF stimulation
MDMs were stimulated with GM-CSF at 100 ng/mL (kindly provided
by A. Lopez, Hanson Centre, Adelaide, Australia), immediately prior to
addition of phagocytic targets. These phagocytic assays always
commenced within 2 min of adding GM-CSF. Lysates were analyzed either
for phagocytosis by a colorimetric assay, for tyrosine-phosphorylated
proteins by immunoblotting, or for Syk phosphorylation by
immunoprecipitation.
Immunoblotting and immunoprecipitation
Cell extracts containing equal amounts of proteins as determined
by DC protein assay (Bio-Rad Laboratories, Hercules, CA) were boiled in
sodium dodecyl sulfate (SDS) sample buffer [10 mM Tris (pH 8.0), 2 mM
EDTA, 1% SDS, 5% ß-mercaptoethanol, 5% glycerol], resolved by
10% SDS-polyacrylamide gel electrophoresis, transferred to
nitrocellulose, and blocked for 2 h in either 3% BSA or 5%
nonfat milk. The blots were probed with a recombinant antibody directed
against phosphotyrosine (RC20; Transduction Laboratories, Lexington,
KY) or paxillin (Transduction Laboratories) overnight at 4°C,
followed by secondary antibody conjugated with horseradish peroxidase
(Amersham Pharmacia, Buckinghamshire, England), and developed for
enhanced chemiluminescence according to manufacturers instructions
(Amersham Pharmacia). Alternatively, to determine the involvement of
various proteins in Fc
R-mediated phagocytosis, cell lysates were
immunoprecipitated with either a rabbit antibody against Hck (gift from
H. C. Cheng, School of Biochemistry, Melbourne University),
anti-Syk mAb (Santa Cruz Biotechnology, Santa Cruz, CA), or
anti-paxillin mAb and then probed with anti-phosphotyrosine antibody
(PY20; Transduction Laboratories) or conversely, immunoprecipitated
with anti-phosphotyrosine mAb and then probed with anti-Pyk2
(Transduction Laboratories) or anti-Syk mAb. Proteins were
immunoprecipitated from extracts with antibodies overnight at 4°C,
collected with 15 µL of protein G-Sepharose beads (1 h of incubation
at 4°C) (Pharmacia Biotech, Uppsala, Sweden), washed five times in
Triton lysis buffer, boiled in SDS sample buffer, resolved by 10%
SDS-polyacrylamide gel electrophoresis, and analyzed by immunoblotting
as described above. To verify the equal protein, input blots were
reprobed with relevant antibodies.
Immunofluorescence microscopy
Cells fixed with 1 mL of 3% Ultrapure formaldehyde
(Polysciences, Warrington, PA) for 20 min were washed twice with cold
0.1 M glycine in PBS-CMF and permeabilized with 0.1% Triton X-100
(Merck, Kilsyth, Australia) for 1 min. After two washes with 1% fetal
bovine serum in PBS-CMF, cells were stained for intracellular proteins
with mouse anti-phosphotyrosine mAb (PY20) or isotype-matched control
IgG1 (MOPC 21; Bionetics, Charleston, SC) for 30 min on ice. After two
washes with cold PBS-CMF, cells were incubated with biotin-conjugated
anti-mouse Ig (Silenus, Melbourne, Australia) for 30 min on ice,
followed by two further washes with cold PBS-CMF. Subsequently, MDMs
were incubated with Texas Red-conjugated streptavidin (Amersham
Pharmacia) for 30 min on ice, washed once with cold PBS-CMF, fixed with
200 µL of 1% formaldehyde, and cytocentrifuged onto glass slides.
Protein tyrosine phosphorylation in both resting and phagocytosing MDMs
was analyzed by confocal laser microscopy (Bio-Rad MRC500). For some
samples, cells were also stained with phalloidin conjugated to Alexa
488 (Molecular Probes, Eugene, OR) to determine colocalization of
F-actin and phosphotyrosine.
| RESULTS |
|---|
|
|
|---|
R-mediated
phagocytosis by MDMs
R-mediated phagocytosis. Phagocytosis of unopsonized E by MDM
cultured in the presence or absence of genistein was below the
detection level of the assay.
|
|
R-mediated phagocytosis by MDMs, we sought to identify the
proteins which were tyrosine phosphorylated in the experiments depicted
in Fig. 1
. Based on estimated size, we investigated several tyrosine
kinases that could potentially be activated during this process.
Enhanced tyrosine phosphorylation of Hck, Syk, and Pyk2 was observed
within 25 min of Fc
R-mediated phagocytosis (Fig. 3
). The input of Syk, Hck, and Pyk2 proteins was standardized
according to Lowrys determinations. Protein levels are shown by
reprobing the blots with relevant antibodies [Fig. 3a
and 3b
(lower
panels)].
|
R-mediated phagocytosis, there was an
increase in paxillin phosphorylation which had declined by 30 min
(Fig. 4a
). Immunoblot analysis of Triton-soluble lysates probed with
anti-paxillin antibody showed that the total level of extracted
paxillin levels changed in a corresponding fashion (Fig. 4b)
. Total
extracted paxillin levels did not vary during phagocytosis when MDMs
were lysed in SDS sample buffer (total cell extract) (Fig. 4c)
. Taken
together, these results suggest that in different phases of
Fc
R-mediated phagocytosis, paxillin is distributed predominantly in
either the cytoskeletal (detergent-insoluble) fraction or cytoplasmic
(detergent-soluble) fraction.
|
R-mediated phagocytosis by GM-CSF
R-mediated phagocytosis by 2030% (Fig. 5a
). GM-CSF stimulated tyrosine phosphorylation of MDM cellular
proteins, and this effect was further augmented during phagocytosis of
IgG-opsonized latex beads (Fig. 5b)
. We next determined whether GM-CSF
directly activated Syk, because in murine macrophages this kinase is a
well-established critical intermediate in Fc
receptor signaling
[3
]. Incubation of MDM with GM-CSF for 2 to 5 min did
not alter the extent of tyrosine phosphorylation of Syk above the
levels observed during Fc
R-mediated phagocytosis (Fig. 5c)
. In
addition, control MDMs which had not been exposed to target particles
did not display detectable Syk phosphorylation in either GM-CSF-treated
or untreated samples. The level of Syk protein was equal for all the
samples (Fig. 5c
, lower panel). Syk coimmunoprecipitated from Triton
lysates with several other phosphoproteins in a reproducible pattern.
This pattern may represent a stable complex of Syk with Fc
receptors and/or other signaling molecules located around the phagosome
because a similar pattern was observed in experiments when MDM lysates
were immunoprecipitated with anti
-chain antibody (data not shown).
Taken together, these data suggest that GM-CSF augments the process of
Fc
R-mediated phagocytosis by triggering tyrosine phosphorylation of
a number of cellular proteins and most probably by acting downstream of
Syk (and, by extension, downstream of Src) in the Fc
R-mediated
cascade or via a pathway parallel to these events.
|
| DISCUSSION |
|---|
|
|
|---|
R-mediated phagocytosis by human
macrophages was mediated by tyrosine phosphorylation of a number of
cellular proteins which localized around the phagocytic cup and that
phagocytosis was blocked by a protein tyrosine kinase inhibitor,
genistein. Both Hck (a macrophage-specific Src family kinase) and Syk
were phosphorylated after engagement of human MDM Fc
receptors.
Here, we also provide the first evidence for activation of Pyk2 and
redistribution of the phosphorylated form of paxillin between the
cytoplasm and cytoskeleton during Fc
R-mediated phagocytosis. In
addition, we show augmentation of Fc
R-mediated phagocytosis by
GM-CSF, concomitant with increased tyrosine phosphorylation of a number
of cellular proteins, which did not however include Syk.
A role for Hck in Fc
R signaling has been suggested, based on data
showing that macrophages prepared from mice deficient in three Src
family tyrosine kinases, Hck, Fgr, and Fyn, exhibit poor signaling
downstream of Fc
R (i.e., Syk activation) as well as reduced levels
of Fc
R-induced functional responses such as phagocytosis, actin cup
formation, and respiratory burst [3
, 33
]. A
specific requirement for Hck in phagocytosis has also been demonstrated
using Hck knock-out mice, which fail to internalize IgG-opsonized E,
while other hemopoietic functions remain intact [34
].
This study also suggested that some functions of Hck are subsumed
through compensatory increases in the activity of another Src kinase,
Lyn, although Lyn could not substitute for Hck in phagocytosis. Both
Hck and Lyn have been shown also to coimmunoprecipitate with Fc
R
after cross-linking of receptors on THP-1 monocytic cell lines
[35
] and human monocytes [36
]. In the
present work we demonstrate activation of Hck during Fc
R-mediated
phagocytosis in human macrophages.
Phosphorylation of ITAM creates docking sites for Syk, a kinase shown
by a number of studies to play a critical role in coupling
phagocytosis-promoting Fc
Rs to the actin-based cytoskeleton
[reviewed in 25]. A study using stem-loop Syk antisense
oligonucleotides in human monocytes [24
], as well as
transfection studies using COS and DT40 cell lines and gene knockout
studies, has demonstrated that Syk activation is absolutely required
for Fc
R-mediated phagocytosis, actin assembly, and Fc
R-mediated
transport to lysosomes [2
, 3
,
8
, 22
]. Furthermore, Syk has also been found
to be a part of the activated Fc
R complex after cross-linking of
receptors in U937 and THP-1 cell lines [37
,
38
]. Our data confirm that Syk is phosphorylated in human
MDMs after Fc
R-mediated phagocytosis.
Activation of Syk is thought to result in the phosphorylation of
various substrates located in the submembranous region beneath
phagocytosed particles, which are required for actin polymerization and
cytoskeletal rearrangement [8
]. Paxillin is a potential
downstream effector of Syk, because this protein has been shown to
interact with a variety of proteins involved in growth control and
cytoskeletal reorganization [reviewed in 28]. The abundance of
binding motifs in paxillin for structural and regulatory proteins has
led to a suggestion that it is important in recruiting signaling
molecules at sites of actin rearrangement and in facilitating their
interaction during phagocytosis [39
]. Paxillin has been
previously shown to be tyrosine phosphorylated in murine peritoneal
macrophages during Fc
R-mediated phagocytosis [6
] and
to colocalize with phagosomes [6
, 26
].
Here, we confirm and extend those observations by showing that the
phosphorylated form of paxillin is redistributed between cytoplasm and
cytoskeleton during phagocytosis in human macrophages.
Paxillin phosphorylation after cell adhesion has been postulated to
involve the kinase p125 FAK, shown previously to bind to paxillin LD
motifs [28
]. The involvement of FAK in Fc
R-mediated
phagocytosis remains controversial, with one study showing no
enhancement of tyrosine phosphorylation of FAK during phagocytosis in
murine macrophages [6
] and another report demonstrating
the expression and phosphorylation of FAK as a result of Fc
R
cross-linking in human monocytes [40
]. However, it has
been reported that human monocytes/macrophages isolated under stringent
conditions and free of platelet contamination do not express FAK [29;
A. Jaworowski, unpublished results). We therefore determined whether
Pyk2, a kinase with 45% sequence identity to FAK [41
],
known to be expressed in human monocytes/macrophages
[29
] and to bind to paxillin [42
], is
activated during Fc
R-mediated phagocytosis. Our results demonstrated
that tyrosine phosphorylation of Pyk2 was increased during
Fc
R-mediated phagocytosis. This is the first report of stimulation
of Pyk2 tyrosine phosphorylation in response to phagocytosis, although
this kinase has been implicated in other processes involving
reorganization of the cytoskeleton, such as locomotion and adhesion
[29
, 43
, 44
].
Fc
R phagocytosis by both human [45
] and murine
[46
] macrophages has been found to be up-regulated by
GM-CSF, a cytokine known to augment a number of macrophage effector
functions [reviewed in 47, 48]. Since GM-CSF receptor does not
possess an intrinsic tyrosine kinase catalytic domain, the activation
of protein tyrosine kinases associated with the ß subunit of the
receptor (Janus kinase, signal-transducing activator of transcription,
and Src families) mediates GM-CSF-stimulated proliferation,
differentiation, and gene expression [49
,
50
]. Stimulation of human monocytes with GM-CSF for
48 h resulted in increased expression of Fc
R II and increased
binding of IgG-opsonized particles [51
]. In our
experiments, short-term pretreatment of MDMs with GM-CSF (25 min) was
unlikely to increase Fc
R expression and de novo receptor synthesis.
Our observations and those of Rossman et al. suggest that GM-CSF may
augment Fc
R-mediated phagocytosis by several mechanisms,
i.e., by stimulating the level of Fc
receptor expression as
well as the phosphorylation of intracellular tyrosine kinases. Because
GM-CSF treatment of MDMs did not enhance phosphorylation of Syk, we
postulate that GM-CSF exerts its stimulatory effect on
Fc
R-phagocytosis by acting either distally to Syk kinase in the
Fc
R-mediated signaling cascade or in a parallel pathway mediated via
Fc
receptor.
Our study shows that the early signaling events during Fc
R-mediated
phagocytosis in human MDMs were similar to those previously
characterized in murine macrophages. In both species, key protein
tyrosine kinases were activated during this process. In addition, we
have demonstrated a novel role for the FAK-related kinase, Pyk2, in
phagocytosis and have provided a baseline for further studies on the
stimulatory role of GM-CSF on macrophage function. Because recent
clinical studies have demonstrated the successful outcome of adjunctive
GM-CSF treatment for opportunistic infections in immunosuppressed
patients [52
, 53
], an understanding of the
mechanism underlying macrophage stimulation by GM-CSF is potentially of
therapeutic benefit.
| ACKNOWLEDGEMENTS |
|---|
The authors thank John Mills for his critical review of the manuscript.
Anthony Jaworowski and Suzanne M. Crowe contributed equally to this work.
Received December 22, 2000; revised April 4, 2001; accepted April 5, 2001.
| REFERENCES |
|---|
|
|
|---|
receptor signaling in macrophages and neutrophils Mol. Cell. Biol. 18,4209-4220This article has been cited by other articles:
![]() |
S. Tsuboi and J. Meerloo Wiskott-Aldrich Syndrome Protein Is a Key Regulator of the Phagocytic Cup Formation in Macrophages J. Biol. Chem., November 23, 2007; 282(47): 34194 - 34203. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Leeansyah, B. D. Wines, S. M. Crowe, and A. Jaworowski The Mechanism Underlying Defective Fc{gamma} Receptor-Mediated Phagocytosis by HIV-1-Infected Human Monocyte-Derived Macrophages J. Immunol., January 15, 2007; 178(2): 1096 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Webster, K. Kedzierska, R. Azzam, G. Paukovics, J. Wilson, S. M. Crowe, and A. Jaworowski Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection J. Leukoc. Biol., February 1, 2006; 79(2): 294 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Scott, F. Zappacosta, E. Y. Kim, R. S. Annan, and W. T. Miller Identification of Novel SH3 Domain Ligands for the Src Family Kinase Hck. WISKOTT-ALDRICH SYNDROME PROTEIN (WASP), WASP-INTERACTING PROTEIN (WIP), AND ELMO1 J. Biol. Chem., July 26, 2002; 277(31): 28238 - 28246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kedzierska, P. Ellery, J. Mak, S. R. Lewin, S. M. Crowe, and A. Jaworowski HIV-1 Down-Modulates {gamma} Signaling Chain of Fc{gamma}R in Human Macrophages: A Possible Mechanism for Inhibition of Phagocytosis J. Immunol., March 15, 2002; 168(6): 2895 - 2903. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |